All locations are open for appointments and procedures. Read our latest visitor policy. Learn more about COVID-19 testing, and get the latest COVID-19 vaccine information.

If you need help accessing our website, call 855-698-9991
Skip to main content
NYU Langone Provider

Kenneth I. Berger, MD

NYU Langone Provider
  • Specialties: Critical Care, Pulmonary Medicine
  • Language: English
  • Phone: 212-263-6117
View Locations

Conditions and Treatments

For Adults
Conditions
  • breathing disorder during sleeping
Treatments
  • lung function test
Learn more about conditions we treat at NYU Langone:
Obstructive Sleep Apnea in Adults

Positions
Board Certifications
  • American Board of Internal Medicine (Critical Care Medicine), 1995
  • American Board of Internal Medicine (Pulmonary Disease), 1994
Education and Training
  • Fellowship, NYU Medical Center, Pulmonary & Critical Care Medicine, 1995
  • Residency, Montefiore Medical Center, Internal Medicine, 1992
  • MD from Boston University, 1989

Is this your profile?

Edit profile

This provider accepts the following insurance plans.

  • Aetna
    • Aetna HMO
    • Aetna Indemnity
    • Aetna Medicare
    • Aetna POS
    • Aetna PPO/EPO
  • Cigna
    • Cigna EPO/POS
    • Cigna PPO
  • Emblem
    • Emblem Select Care Exchange
  • Empire Blue Cross Blue Shield
    • Empire Blue Cross Blue Shield EPO
    • Empire Blue Cross Blue Shield HMO
    • Empire Blue Cross Blue Shield Indemnity
    • Empire Blue Cross Blue Shield MediBlue
    • Empire Blue Cross Blue Shield POS
    • Empire Blue Cross Blue Shield PPO
  • GHI
    • GHI HMO
View All Accepted Plans This list of insurances changes regularly, and insurance plans listed may not be accepted at all office locations for this provider. Before your appointment, please confirm with your insurance company that this provider accepts your insurance.

Locations and Appointments

NYU Pulmonary & Critical Care Associates

240 East 38th Street
New York, NY 10016

Phone

212-263-6117

View Map

  • A Phase 3 Open-label Extension Study to Assess the Long-term Safety and Efficacy of Intravenous ATB200 Co-administered With Oral AT2221 in Adult Subjects With Late-onset Pompe Disease

    Learn More

  • Microbial and human biomarkers of thoracic disease after lung transplantation

    Learn More

  • Amicus ATB200-03 POMPE CDA

    Learn More
View All Research Studies (3)

Read All Publications (137)